passages: 3984
passages: document
passages: [ Antazoline/tetryzoline eyedrops in comparison with levocabastine eyedrops in acute allergic conjunctivitis ] . BACKGROUND Allergic conjunctivitis is one of the most frequent allergic diseases of the anterior eye segment . METHODS This multicentre , clinical trial was an investigation to compare the antiallergic efficacy , local tolerance and safety of Antazolin/Tetryzolin eye drops and Levocabastine eye drops . 69 patients were treated over a 2 weeks course of therapy . The subjective and objective ocular symptoms were documented over the treatment period . RESULTS Both eye drops reduced subjective and objective ocular symptoms effective . The difference between the treatments ( p = 0.0395 ) was the faster onset of action of Antazolin/Tetryzolin 30 minutes after administration of the first drop of trial medication . CONCLUSION A fast and effective onset of action is of high clinical relevance . Therefore the benefits of using Antazolin/Tetryzolin eye drops was clearly outweigh .
entities: 3985
entities: Intervention_Pharmacological
entities: Antazoline/tetryzoline
entities: 3986
entities: Intervention_Pharmacological
entities: levocabastine
entities: 3987
entities: Intervention_Pharmacological
entities: Antazolin/Tetryzolin
entities: 3988
entities: Intervention_Pharmacological
entities: Levocabastine
entities: 3989
entities: Intervention_Pharmacological
entities: Antazolin/Tetryzolin
entities: 3990
entities: Intervention_Pharmacological
entities: Antazolin/Tetryzolin
entities: 3991
entities: Outcome_Physical
entities: subjective and objective ocular symptoms
entities: 3992
entities: Outcome_Physical
entities: subjective and objective ocular symptoms
entities: 3993
entities: Outcome_Physical
entities: onset of action
entities: 3994
entities: Participant_Condition
entities: acute allergic conjunctivitis ]
entities: 3995
entities: Participant_Sample-size
entities: 69 patients